Skip to main content
editorial
. 2020 Jan 17;5(4):214–220. doi: 10.1016/j.cdtm.2019.12.005

Table 2.

Monogenic cardiovascular diseases that have been suggested by relevant guidelines, consensus, or recommendations for genetic testing.

Monogenic cardiovascular diseases Guideline/Consensus
Hypertrophic cardiomyopathy
  • 1.

    Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline4
  • 2.

    2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy5

  • 3.

    2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy6

  • 4.

    2017 Guidelines for the diagnosis and treatment for Chinese adult patients with hypertrophic cardiomyopathy7

  • 5.

    2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death8

Arrhythmogenic right ventricular cardiomyopathy
  • 1.

    Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline4
  • 2.

    2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death8

Familial dilated cardiomyopathy
  • 1.

    Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline4
Cardiac ion channel diseases
  • 1.

    Chinese expert consensus on diagnosis and treatment of inherited primary arrhythmia syndrome 20159
  • 2.

    China expert consensus statement on genetic testing for cardiac channelopathies and cardiomyopathies10

  • 3.

    HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies11

  • 4.

    Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement from AHA/ACC12

  • 5.

    International recommendations for electrocardiographic interpretation in athletes13

  • 6.

    2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death8

Monogenic inherited hypertension
  • 1.

    2018 ESC/ESH Guidelines for the management of arterial hypertension14
  • 2.

    Consensus Statement on next generation-sequencing-based diagnostic testing of hereditary pheochromocytomas and paraganglioma15

  • 3.

    Expert consensus on diagnosis and treatment of pheochromocytoma and paraganglioma16

Inherited aortic diseases
  • 1.

    Editor's Choice - Management of descending thoracic aorta diseases: clinical practice guidelines of ESVS17
Pulmonary hypertension
  • 1.

    2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension18
  • 2.

    Guidelines on the diagnosis and treatment of pulmonary hypertension in China 201819

  • 3.

    Guidelines on the diagnosis and treatment of pulmonary hypertension: summary of recommendations20

Familial hypercholesterolemia
  • 1.

    Homozygous familial hypercholesterolemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolemia of EAS21
  • 2.

    2019 ESC/EAS Guidelines for the management of dyslipidemias: lipid modification to reduce cardiovascular risk22

ACC: the American College of Cardiology; ACCF: the American College of Cardiology Foundation; AHA: the American Heart Association; EAS: European Atherosclerosis Society; EHRA: the European Heart Rhythm Association; ERS: the European Respiratory Society; ESC: the European Society of Cardiology; ESH: the European Society of Hypertension; ESVS: the European Society for Vascular Surgery; HRS: the Heart Rhythm Society.